Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Developments in biological standardization

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9272363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor

  1995cited by this paper
• Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity

  1993cited by this paper
• Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model

  1993cited by this paper
• Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis

  1991cited by this paper
• Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection

  1991cited by this paper
• Human TH1 and TH2 subsets: doubt no more.

  1991cited by this paper
• Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells

  1984cited by this paper

• "Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis Vaccine-primed Host Responses in the Baboon Model".

  2023cites this paper
• Modification of innate immune responses to Bordetella pertussis in babies from pertussis vaccinated pregnancies

  2021cites this paper
• A Novel Outbred Mouse Model to Study Lung Memory Immunological Response Induced by Pertussis Vaccines.

  2020cites this paper
• Immunological Response Induced by Pertussis Vaccines A Novel Outbred Mouse Model to Study Lung Memory

  2020cites this paper
• Diphteria-tetanus-pertussis vaccine reduces specific IgE, inflammation and remodelling in an animal model of mite-induced respiratory allergy.

  2020cites this paper
• Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines

  2019cites this paper
• Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation

  2019cites this paper
• Subcutaneous Immunization with Recombinant Lactococcus lactis Expressing F1S1 Fusion Protein Induces Systemic and Mucosal Immune Responses in BALB/C Mice.

  2019cites this paper
• Subcutaneous administration of a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis induces mucosal and systemic immune responses

  2018cites this paper
• Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model.

  2017cites this paper
• Immune responses in perinatal brain injury.

  2017cites this paper
• Efeito da vacina Bordetella pertussis na prevenção da doença pulmonar alérgica por Dermatophagoides pteronyssinus em um modelo animal

  2015cites this paper
• Estudio de la estimulación de la respuesta innata en mucosas inducida por agonistas en la protección contra pertussis , una enfermedad considerada resurgente

  2015cites this paper
• Challenges for Use in Neonates: Opportunities and Vaccines against Respiratory Viral Pathogens

  2014cites this paper
• Vaccines against Respiratory Viral Pathogens for Use in Neonates: Opportunities and Challenges

  2014cites this paper
• Immune Responses to Pertussis Antigens in Infants and Toddlers after Immunization with Multicomponent Acellular Pertussis Vaccine

  2014cites this paper
• Title: Immune Responses to Pertussis Antigens in Infants and Toddlers after

  2014cites this paper
• Réponses immunitaires du grand prématuré à la vaccination contre la coqueluche

  2013cites this paper
• Immunity to the respiratory pathogen Bordetella pertussis

  2012cites this paper
• Vaccination of neonates: problem and issues.

  2012cites this paper
• infection in a rodent model of bordetellosis parapertussis Bordetella Acellular pertussis vaccination facilitates

  2010cites this paper
• Autism Spectrum Disorders May Be Due to Cerebral Toxoplasmosis Associated with Chronic Neuroinflammation Causing Persistent Hypercytokinemia that Resulted in an Increased Lipid Peroxidation, Oxidative Stress, and Depressed Metabolism of Endogenous and Exogenous Substances.

  2010cites this paper
• Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis

  2010cites this paper
• Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.

  2008cites this paper
• Pertussis Toxin Utilizes Proximal Components of the T-Cell Receptor Complex To Initiate Signal Transduction Events in T Cells

  2007cites this paper
• Consequences of the expression of lipopolysaccharide-modifying enzymes for the efficacy and reactogenicity of whole-cell pertussis vaccines.

  2007cites this paper
• Expression of the Lipopolysaccharide-Modifying Enzymes PagP and PagL Modulates the Endotoxic Activity of Bordetella pertussis

  2006cites this paper
• Effect of Different Forms of Adenylate Cyclase Toxin of Bordetella pertussis on Protection Afforded by an Acellular Pertussis Vaccine in a Murine Model

  2006cites this paper
• Common vaccine antigens inhibit allergen‐induced sensitization and airway hyperresponsiveness in a murine model

  2006cites this paper
• Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.

  2005cites this paper
• Bacterial toxins: potential weapons against HIV infection.

  2005cites this paper
• Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies

  2005cites this paper
• Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors

  2005cites this paper
• Acellular Bordetella pertussis vaccine enhances mucosal interleukin‐10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Gαi2‐deficient mice

  2005cites this paper
• Immunological development of preterm infants in early infancy

  2005cites this paper
• Ethnicity, infection and sudden infant death syndrome.

  2004cites this paper
• The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.

  2004cites this paper
• Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice 1

  2003cites this paper
• The Use of DNA Vaccines for Neonatal/Early Life Childhood Immunization

  2003cites this paper
• Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.

  2003cites this paper
• Neonatal Mice Product-Specific Antibody Responses in Vaccine Carriers Induce Transgene Mucosally Delivered E1-Deleted Adenoviral

  2003cites this paper
• Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns

  2002cites this paper
• Immunological adjuvants efficiently induce antigen-specific T cell responses in old mice: implications for vaccine adjuvant development in aged individuals.

  2002cites this paper
• Quantitative Priming with Inactivated Pertussis Toxoid Vaccine in the Aerosol Challenge Model

  2002cites this paper
• Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen.

  2002cites this paper
• Childhood vaccinations and risk of asthma

  2002cites this paper
• Immunization Safety Review: Multiple Immunizations and Immune Dysfunction

  2002cites this paper
• Structural and immunological studies of pertussis toxin: effect of toxoiding

  2002cites this paper
• Neonatal and early life vaccinology.

  2001cites this paper
• Mechanisms of Bordetella pathogenesis.

  2001cites this paper
• Antibodies to BrkA augment killing of Bordetella pertussis.

  2001cites this paper
• Immunity to Bordetella pertussis.

  2001cites this paper
• Down-Regulation of IgE and IgG4 Antibodies to Tetanus Toxoid and Diphtheria Toxoid by Covaccination with Cellular Bordetella pertussis Vaccine1

  2001cites this paper
• Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection.

  2000cites this paper
• Vaccination in the Neonatal Period and Early Infancy

  2000cites this paper
• Protective Effects of Pertussis Immunoglobulin (P-IGIV) in the Aerosol Challenge Model

  1999cites this paper
• T-cell function in newborn mice and humans.

  1999cites this paper
• Vitamin A and immunity to viral, bacterial and protozoan infections

  1999cites this paper
• Humoral and Cellular Immune Responses in Mice Immunized with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Producing a Pertussis Toxin-Tetanus Toxin Hybrid Protein

  1999cites this paper
• T-cell response to inhaled antigen.

  1998cites this paper
• A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis

  1998cites this paper
• Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children

  1998cites this paper
• Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain Genes

  1997cites this paper
• Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells

  1996cites this paper